enGene Holdings Inc. financial data

Symbol
ENGN, ENGNW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
4868 Rue Levy, Suite 220, Saint Laurent, Quebec, Canada
State of incorporation
Canada (Federal Level)
Fiscal year end
October 31
Latest financial report
10-Q - Q2 2024 - Sep 10, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.22K %
Debt-to-equity 18.5 %
Return On Equity -80.5 %
Return On Assets -67.9 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 44.2M shares
Common Stock, Shares, Outstanding 44.2M shares
Entity Public Float 43.8M USD
Common Stock, Value, Issued 453M USD
Weighted Average Number of Shares Outstanding, Basic 44.2M shares +6198%
Weighted Average Number of Shares Outstanding, Diluted 44.2M shares +6198%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 32.7M USD +196%
General and Administrative Expense 22.6M USD +122%
Operating Income (Loss) -55.3M USD -168%
Nonoperating Income (Expense) -67.1M USD +69%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -122M USD -200%
Income Tax Expense (Benefit) -21K USD
Net Income (Loss) Attributable to Parent -122M USD -200%
Earnings Per Share, Basic 121 USD/shares -96.3%
Earnings Per Share, Diluted 121 USD/shares -96.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 258M USD
Assets, Current 263M USD
Property, Plant and Equipment, Net 1.01M USD
Operating Lease, Right-of-Use Asset 1.79M USD
Other Assets, Noncurrent 1.38M USD
Assets 267M USD
Accounts Payable, Current 2.86M USD
Employee-related Liabilities, Current 2.92M USD
Liabilities, Current 13.5M USD
Operating Lease, Liability, Noncurrent 1.48M USD
Liabilities 36.6M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.02M USD
Retained Earnings (Accumulated Deficit) -239M USD
Stockholders' Equity Attributable to Parent 230M USD
Liabilities and Equity 267M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -7.37M USD -18.4%
Net Cash Provided by (Used in) Financing Activities 12M USD
Net Cash Provided by (Used in) Investing Activities -506K USD -3792%
Common Stock, Shares, Issued 44.2M shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 4.13M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 81.5M USD +299%
Interest Paid, Excluding Capitalized Interest, Operating Activities 283K USD
Deferred Tax Assets, Valuation Allowance 31.1M USD +41%
Deferred Tax Assets, Gross 31.1M USD +40.5%
Operating Lease, Liability 1.9M USD
Depreciation 80K USD +73.9%
Payments to Acquire Property, Plant, and Equipment 506K USD +3792%
Lessee, Operating Lease, Liability, to be Paid 3.39M USD
Property, Plant and Equipment, Gross 2.54M USD
Operating Lease, Liability, Current 422K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 468K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 456K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.49M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 327K USD
Deferred Tax Assets, Operating Loss Carryforwards 18.9M USD +36.5%
Preferred Stock, Shares Issued 0 shares
Lessee, Operating Lease, Liability, to be Paid, Year Four 303K USD
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 314K USD +90.7%
Share-based Payment Arrangement, Expense 7.02M USD +3846%
Interest Expense 728K USD -38.1%